Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease

Medicine & Life Sciences

• Bariatric Surgery 100%
• Non-alcoholic Fatty Liver Disease 96%
• Odds Ratio 24%
• Hospitalization 23%
• Confidence Intervals 22%
• Metformin 13%
• Metabolic Diseases 13%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
• Metabolic Syndrome 11%
• SARS Virus 9%
• Glucagon-Like Peptide-1 Receptor 8%
• Polymerase Chain Reaction 7%
• Morbidity 7%
• Inflammation 7%
• Venous Thromboembolism 6%
• Adiposity 6%
• Electronic Health Records 6%
• Mortality 6%
• Social Class 6%
• Prescriptions 5%
• Observational Studies 4%
• Thrombosis 4%
• Obesity 4%
• Therapeutics 4%
• Logistic Models 4%
• Delivery of Health Care 3%